Literature DB >> 19752159

Epilepsy and mental retardation limited to females with PCDH19 mutations can present de novo or in single generation families.

Kim Hynes1, Patrick Tarpey, Leanne M Dibbens, Marta A Bayly, Samuel F Berkovic, Raffaella Smith, Zahyia Al Raisi, Samantha J Turner, Natasha J Brown, Tarishi D Desai, Eric Haan, Gillian Turner, John Christodoulou, Helen Leonard, Deepak Gill, Michael R Stratton, Jozef Gecz, Ingrid E Scheffer.   

Abstract

BACKGROUND: Epilepsy and mental retardation limited to females (EFMR) is an intriguing X-linked disorder affecting heterozygous females and sparing hemizygous males. Mutations in the protocadherin 19 (PCDH19) gene have been identified in seven unrelated families with EFMR. METHODS AND
RESULTS: Here, we assessed the frequency of PCDH19 mutations in individuals with clinical features which overlap those of EFMR. We analysed 185 females from three cohorts: 42 with Rett syndrome who were negative for MECP2 and CDKL5 mutations, 57 with autism spectrum disorders, and 86 with epilepsy with or without intellectual disability. No mutations were identified in the Rett syndrome and autism spectrum disorders cohorts suggesting that despite sharing similar clinical characteristics with EFMR, PCDH19 mutations are not generally associated with these disorders. Among the 86 females with epilepsy (of whom 51 had seizure onset before 3 years), with or without intellectual disability, we identified two (2.3%) missense changes. One (c.1671C-->G, p.N557K), reported previously without clinical data, was found in two affected sisters, the first EFMR family without a multigenerational family history of affected females. The second, reported here, is a novel de novo missense change identified in a sporadic female. The change, p.S276P, is predicted to result in functional disturbance of PCDH19 as it affects a highly conserved residue adjacent to the adhesion interface of EC3 of PCDH19.
CONCLUSIONS: This de novo PCDH19 mutation in a sporadic female highlights that mutational analysis should be considered in isolated instances of girls with infantile onset seizures and developmental delay, in addition to those with the characteristic family history of EFMR.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19752159     DOI: 10.1136/jmg.2009.068817

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  21 in total

1.  Genetics of Epilepsy in Clinical Practice.

Authors:  Samuel F Berkovic
Journal:  Epilepsy Curr       Date:  2015 Jul-Aug       Impact factor: 7.500

Review 2.  Epilepsy genetics--past, present, and future.

Authors:  Annapurna Poduri; Daniel Lowenstein
Journal:  Curr Opin Genet Dev       Date:  2011-01-27       Impact factor: 5.578

Review 3.  Regulation of neural circuit formation by protocadherins.

Authors:  Stacey L Peek; Kar Men Mah; Joshua A Weiner
Journal:  Cell Mol Life Sci       Date:  2017-06-19       Impact factor: 9.261

4.  Interference Resolved: Sorting out Picky Protocadherins in Epilepsy.

Authors:  Christina Gross
Journal:  Epilepsy Curr       Date:  2018 May-Jun       Impact factor: 7.500

Review 5.  Seizures and X-linked intellectual disability.

Authors:  Roger E Stevenson; Kenton R Holden; R Curtis Rogers; Charles E Schwartz
Journal:  Eur J Med Genet       Date:  2012-02-08       Impact factor: 2.708

Review 6.  Non-clustered protocadherin.

Authors:  Soo-Young Kim; Shin Yasuda; Hidekazu Tanaka; Kanato Yamagata; Hyun Kim
Journal:  Cell Adh Migr       Date:  2011-03-01       Impact factor: 3.405

Review 7.  Genetics, molecular biology, and phenotypes of x-linked epilepsy.

Authors:  Hao Deng; Wen Zheng; Zhi Song
Journal:  Mol Neurobiol       Date:  2013-11-22       Impact factor: 5.590

8.  PCDH19-related epilepsy is associated with a broad neurodevelopmental spectrum.

Authors:  Lacey Smith; Nilika Singhal; Christelle M El Achkar; Gessica Truglio; Beth Rosen Sheidley; Joseph Sullivan; Annapurna Poduri
Journal:  Epilepsia       Date:  2018-01-28       Impact factor: 5.864

9.  Clinical and genetic aspects of PCDH19-related epilepsy syndromes and the possible role of PCDH19 mutations in males with autism spectrum disorders.

Authors:  J J T van Harssel; S Weckhuysen; M J A van Kempen; K Hardies; N E Verbeek; C G F de Kovel; W B Gunning; E van Daalen; M V de Jonge; A C Jansen; R J Vermeulen; W F M Arts; H Verhelst; A Fogarasi; J F de Rijk-van Andel; A Kelemen; D Lindhout; P De Jonghe; B P C Koeleman; A Suls; E H Brilstra
Journal:  Neurogenetics       Date:  2013-01-20       Impact factor: 2.660

10.  Identification of SCN1A and PCDH19 mutations in Chinese children with Dravet syndrome.

Authors:  Anna Ka-Yee Kwong; Cheuk-Wing Fung; Siu-Yuen Chan; Virginia Chun-Nei Wong
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.